Article info
PDFOriginal research
MYCN amplification and International Neuroblastoma Risk Group stratification on fine-needle aspiration biopsy and their correlation to survival in neuroblastoma
- Correspondence to Dr Radhika Srinivasan, Cytology & Gynecological Pathology, Post Graduate Institute of Medical Education and Research, Chandigarh 160012, Chandigarh, India; drsradhika{at}gmail.com
Citation
MYCN amplification and International Neuroblastoma Risk Group stratification on fine-needle aspiration biopsy and their correlation to survival in neuroblastoma
Publication history
- Received January 20, 2022
- Accepted March 25, 2022
- First published April 12, 2022.
Online issue publication
August 17, 2023
Article Versions
- Previous version (17 August 2023).
- You are viewing the most recent version of this article.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
© Author(s) (or their employer(s)) 2023. No commercial re-use. See rights and permissions. Published by BMJ.